Browse > Article
http://dx.doi.org/10.4062/biomolther.2010.18.1.092

Lycopene Inhibits Proliferation, Invasion and Migration of Human Breast Cancer Cells  

Koh, Min-Soo (College of Pharmacy, Duksung Women's University)
Hwang, Jin-Sun (College of Pharmacy, Duksung Women's University)
Moon, A-Ree (College of Pharmacy, Duksung Women's University)
Publication Information
Biomolecules & Therapeutics / v.18, no.1, 2010 , pp. 92-98 More about this Journal
Abstract
Breast cancer has been estimated as one of the most common causes of cancer death among women. The major cause of death from breast cancer is the metastatic spread of the disease from the primary tumor to distant sites in the body. Lycopene is one of the major carotenoids in fruits and vegetables including tomatoes. Epidemiological studies have shown that the dietary intake of lycopene is associated with decreased risk of cancer. Although mounting evidence shows the chemopreventive effect of lycopene, the role of lycopene in the prevention of metastatic potential of breast cancer has not been determined yet. In the present study, we investigated the inhibitory effect of lycopene on invasive and migratory phenotypes of two highly aggressive breast cancer cell lines, H-Ras-transformed MCF10A human breast epithelial cells (H-Ras MCF10A) and MDA-MB-231 human breast cancer cells. Here, we report that lycopene significantly inhibits invasion and migration as well as proliferation of H-Ras MCF10A and MDA-MB-231 cells. This study suggested an in vitro anti-cancer and anti-metastatic potential of lycopene. We also showed that activations of ERKs and Akt were inhibited by lycopene in H-Ras MCF10A cells, suggesting that the ERKs and Akt signaling pathways may be involved in lycopene-induced anti-proliferative and/or anti-invasive/migratory effects in these cells. Taken in conjunction with the fact that breast cancer metastasis is one of the most lethal malignancies in women, our findings may provide useful information for the application of lycopene in establishing strategy to prevent the metastatic breast cancer.
Keywords
Lycopene; H-Ras MCF10A; MDA-MB-231; Invasion; Breast cancer;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Clair, T., Miller, W. and Cho-Chung, Y. (1987). Prognostic significance of the expression of the ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res. 49, 5290-5293.
2 Cunningham, F. X. Jr., Sun, Z., Chamovitz, D., Hirschberg, J. and Gantt, E. (1994). Molecular structure and enzymatic function of lycopene cyclase from the Cyanobacterium Synechococcus sp Strain PCC7942. Plant. Cell. 6, 1107-1121.   DOI
3 DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E. and Taylor, S. M. (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52, 701-708.
4 Ferguson, L. R. (1994). Antimutagens as cancer chemopreventive agents in the diet. Mut. Res. 307, 395-410.   DOI   ScienceOn
5 Franceschi, S., Bidoli, E., LaVeccia, C., Talamini, R., D'Avanzo, B. and Negri, E. (1994). Tomatoes and risk of digestive tract cancers. Int. J. Cancer 59, 181-184.   DOI
6 Freemantle, S. J., Spinella, M. J. and Dmitrovsky, E. (2003). Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305-7315.   DOI
7 Hwang, E. S. and Bowen, P. E. (2004). Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J. Med. Food 7, 284-289.   DOI
8 Hwang, E. S. and Lee, H. J. (2006). Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Exp. Biol. Med. 231, 322-327.   DOI
9 Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, M. J. (2007). Cancer Statistics. CA Cancer J. Clin. 57, 43-66.   DOI
10 Kim, E. S., Jeong, J. B., Kim, S., Lee, K. M., Ko, E., Noh, D. Y., Hwang, K. T., Ha, J. H., Lee, C. H., Kim, S. G. and Moon, A. (2010). The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion. Breast Cancer Res. Treat. [Epub ahead of print].
11 Kim, I. Y. and Moon, A. (2004). Inhibition of invasive phenotype and induction of apoptosis in human breast cancer cells by chemopreventive agents. J. Korean Assoc. Cancer Prev. 9, 59-67.
12 Kim, L., Rao, A. V. and Rao, L. G. (2002). Effect of lycopene on prostate LNCaP cancer cells in culture. J. Med. Food 5, 181-187.   DOI
13 Boileau, A. C., Merchen, N. R., Wasson, K., Atkinson, C. A. and Erdman, J. W. (1999). Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J. Nutr. 129, 1176-1181.   DOI
14 Chan, C. M., Fang, J. Y., Lin, H. H., Yang, C. Y. and Hung, C. F. (2009). Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways. Biochem. Biophys. Res. Commun. 388, 172-176.   DOI
15 Moon, A., Kim, M. S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q. and Kim, H. R. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer 85, 176-181.   DOI
16 Nagasawa, H., Mitamura, T., Sakamoto, S. and Yamamoto, K. (1995). Effects of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res. 15, 1173-1178.
17 Rao, A. V. and Agarwal, S. (2000). Role of anti-oxidant lycopene in cancer and heart disease. J. Am. Coll. Nutr. 19, 563-569.   DOI
18 Omoni, O. A. and Aluko, E. R. (2005). The anti-carcinogenic and anti-atherogenic effects of lycopene: a review. Trends Food Sci. Technol. 16, 344-350.   DOI
19 Prakash, P., Russell, R. M. and Krinsky, N. I. (2001). In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. J. Nutr. 131, 1574-1580.   DOI
20 Rao, A. V. and Agarwal, S. (1999). Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nut. Res. 19, 305-323.   DOI
21 Giovannucci, E. (1999). Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer Inst. 91, 317-331.   DOI
22 Huang, C. S., Fan, Y. E., Lin, C. Y. and Hu, M. L. (2007). Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem. 18, 449-456.   DOI
23 Huang, C. S., Liao, J. W. and Hu, M. L. (2008). Lycopene inhibits experimental metastasis of human hepatoma SKHep-1 cells in athymic nude mice. J. Nutr. 138, 538-543.   DOI
24 Stahl, W. and Sies, H. (1996). Lycopene: a biologically important carotenoid for humans? Arch. Biochem. Biophys. 336, 1-9.   DOI
25 Stavric, B. (1994). Role of chemopreventers in human diet. Clinical Biochem. 27, 319-332.   DOI
26 Weisburger, J. H. (2002). Lycopene and tomato products in health promotion. Exp. Biol. Med. 227, 924-927.   DOI
27 Agarwal, S. and Rao, V. A. (2000). Tomato lycopene and its role in human health and chronic diseases. CMJA. 163, 739-744.
28 Arab, L. and Steck, S. (2000). Lycopene and cardiovascular disease. Am. J. Clin. Nutr. 71 Suppl, 1691S-1695S.   DOI
29 Chiang, H. S., Wu, W. B., Fang, J. Y., Chen, D. F., Chen, B. H., Huang, C. C., Chen, Y. T. and Hung, C. F. (2007). Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Life Sci. 81, 1509-1517.   DOI
30 Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-557.   DOI
31 Wu, K., Schwatz, S. J., Platz, E. A., Clinton, S. K., Erdman, J. W., Ferruzzi, M. G., Willett W. C. and Giovannucci E. L. (2003). Variations in plasma lycopene and specific isomers over time in a cohort of US men. J. Nutr. 133, 1930-1936.   DOI
32 Yang, E. and Korsmeyer, S. J. (1996). Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88, 386-401.
33 Kim, M. S., Lee, E. J., Kim, H. R. and Moon, A. (2003). p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63, 5454-5461.
34 Levy, J., Bosin, E., Feldman, B., Giat, Y., Miinster, A., Danilenko, M. and Sharoni, Y. (1995). Lycopene is a more potent inhibitor of human cancer cell proliferation than either $\alpha$-carotene or $\beta$-carotene. Nutr. Cancer 24, 257-266.   DOI
35 Liotta, L. A., Abe, S., Robey, P. G. and Martin, G. R. (1979). Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Natl. Acad. Sci. U.S.A. 76, 2268-2272.   DOI
36 Song, H., Ki, S. H., Kim, S. G. and Moon, A. (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487-10496.   DOI
37 Salman, H., Bergman, M., Djaldetti, M. and Bessler, H. (2007). Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed. Pharmacother. 61, 366-369.   DOI
38 Shi, J. (2000). Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit. Rev. Food Sci. Nutr. 40, 1-42.   DOI
39 Shin, I., Kim, S., Song, H., Kim, H. R. and Moon, A. (2005). H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem. 280, 14675-14683.   DOI